Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-20

Clinical Trial Update: The Neurodevelopmental and Behavioral Phenotyping Screening Protocol

View source ↗

Summary

The Neurodevelopmental and Behavioral Phenotyping Screening Protocol is an NIMH-sponsored clinical trial protocol currently recruiting, investigating phenotypin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Neurologic Disorders, Autism | Status: RECRUITING